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Abstract (250 words) 
Background: Few studies have investigated the association of different measures of adiposity with 
carotid plaque. 
Aims: To investigate and compare the associations of four measures of adiposity: body mass index 
(BMI), waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) with 
the presence of carotid plaque and total plaque area (TPA) in the right carotid artery.  
Methods: We included 4906 individuals aged 31-88 years who participated in a population-based 
study with ultrasonography of the right carotid artery. Adiposity measures were converted to sex-
specific SD units to allow comparison of effect sizes. TPA was log transformed due to its skewed 
distribution. Logistic and linear regression models were used respectively to investigate the 
association of each adiposity measure with the presence of plaque and with log-transformed TPA. 
Estimates were adjusted for potential confounders and mediators such as blood pressure and lipids. 
Results: After adjustment for age, sex, smoking, and education level, there was strong evidence of an 
association between all adiposity measures and log-transformed TPA, whereas only WHR was weakly 
associated with presence of plaque. WHR showed the largest adjusted effect size for both log-
transformed TPA (beta 0.055, 95%CI 0.028-0.081) and the presence of plaque (OR 1.07, 95%CI 1.01-
1.15). Adjustment for mediators led to appreciable attenuation of observed effects. 
Conclusions: Adiposity is more consistently associated with extent of plaque burden than with 
whether an individual does or does not have any plaque. There was evidence that established 
biomarkers mediate much of this association. Abdominal adiposity appears to show the strongest 
effect.  
Key words: Atherosclerosis, carotid plaque, adiposity, anthropometric measures, waist-to-hip ratio 
(WHR) 
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Introduction 
Obesity is a global epidemic, affecting an increasing proportion of the world’s population (1). In 
2014, approximately 40% of adults worldwide were estimated to be overweight, and 13% obese (2). 
This trend is alarming because it might be expected to result in a steep increase in non-communicable 
diseases, particularly cardiovascular disease (CVD) which is the leading cause of death worldwide. 
Obesity contributes to CVD through a variety of pathways including hypertension, hyperlipidemia, 
and diabetes (3). A better understanding of the pathways through which obesity affects CVD risk may 
contribute to developing interventions to mitigate the effect of this modifiable risk. Furthermore, it is 
known that to achieve sufficient weight-loss and to sustain it for a long-term is relatively difficult 
while the control of hypertension, hyperlipidemia, and diabetes are well-established (4, 5). 
Many studies have investigated the association between various adiposity measures and subclinical 
carotid atherosclerosis (6). However, most of these have focussed on carotid intima-media thickness 
(IMT). Studies using carotid plaque as an outcome are scarce, and most of them use the binary 
indicator of presence or absence of plaque (7-15). Although studies have consistently shown that 
increased IMT predicts future CVD events, increased IMT does not necessarily reflect atherosclerotic 
changes of the carotid artery and can be caused by other mechanisms (16). In contrast, the presence of 
carotid plaque is characteristic of a later stage of atherosclerosis and thus, not surprisingly, predicts 
future CVD events better than IMT (17). Beyond this, a quantitative measure of carotid plaque 
burden, such as total plaque area (TPA), has also been shown to be strongly predictive of future CVD 
events (18, 19). 
A small number of studies have investigated the association of body mass index (BMI) with 
quantitative measures of carotid plaque burden, although they failed to demonstrate a significant 
association (13, 20). However, BMI has limitations as a measure of adiposity (21). It neither  
differentiates between fat and lean mass nor does it reflect body fat distribution. Accumulating 
evidence suggests that abdominal obesity may be correlated with CVD risks more strongly than 
general obesity, reflecting a more important role of visceral adipose tissues in the development of 
CVD (22). Waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR) 
are easily evaluated in a routine clinical setting and reflect abdominal obesity better than BMI. To our 
knowledge, associations of plaque burden with these alternative measures of adiposity have not been 
investigated.  
The aim of our study was to evaluate the associations between four adiposity measures (BMI, WC, 
WHR, WHtR) and plaque presence (yes/no) as well as TPA in a population-based sample. In addition, 
we investigated the extent to which established CVD risk factors mediated any such associations. We 
used the Norwegian Tromsø Study which is one of few population-based studies that have 
quantitative plaque measures as well as multiple measures of adiposity.  
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Materials and Methods 
Participants 
Subjects in this analysis participated in the fifth survey of the Tromsø Study (Tromsø 5) conducted in 
2001-02. The Tromsø Study is a large population-based study with repeated health surveys conducted 
in the municipality of Tromsø, Norway, which started in 1974. Details of the Tromsø Study have been 
published previously (23).  
The study consisted of two parts: a first visit that collected data via questionnaires, interviews, 
physical examinations and biological samples, and a second visit at which more extensive clinical 
examinations were conducted, including carotid ultrasonography. A total of 10353 people aged 30-89 
years were invited to the first visit, and 8130 people attended (23). A subset of 6969 participants 
among those who attended the first visit were invited to the second visit, of whom 5952 attended. The 
Regional Committee for Research Ethics approved the study, and The Norwegian Data Inspectorate 
licensed the data. 
First visit measurements 
Height, weight, waist and hip circumference were measured using standard methods. Blood pressure 
was measured using Dinamap Vital Signs Monitor 1846l. After a 2-minute rest, three measurements 
were taken with one-minute intervals, with the participant in a sitting position. The mean of the two 
final readings was used in the analysis. Smoking habit, length of education (years), and medical 
history (hypertension, diabetes, CVD) were collected from self-administered questionnaires. A non-
fasting blood sample was obtained. Serum total cholesterol and triglycerides were analyzed with 
enzymatic colorimetric methods. Serum high-density lipoprotein (HDL) cholesterol was measured 
after separating apoB containing lipoproteins by using heparin and manganese chloride (24). Low-
density lipoprotein (LDL) cholesterol was calculated using the Friedewald equation. 
Ultrasound examination 
By design, the carotid plaque examinations excluded those who had not had a carotid ultrasound 
examination in the Tromsø 4 study (1994-95). This meant that of those who attended the second visit 
(N=5952), carotid ultrasound examinations in Tromsø 5 were conducted on only 5453 participants, of 
whom data was available for analysis for 5423. 
Carotid plaque was assessed by recording ultrasonographic images of the right carotid artery using an 
Acuson Xp10 128 ART ultrasound scanner equipped with a linear array 5-7 MHz transducer. 
Participants were in a supine position during the examination. 
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The plaque was defined as a localized protrusion of the vessel wall into the lumen of at least 50% 
compared with the adjacent intima-media thickness. The near and far wall of the common carotid 
artery, bifurcation, and internal carotid artery were examined to seek plaques, and a score was 
calculated based on the presence of plaque in each location up to a maximum of six. For each plaque 
identified, a longitudinal still plaque image was recorded. Subsequent offline reading was undertaken 
to measure plaque area using a semi-automatic border detection software Arterial Measurement 
System (AMS) that involved the operator outlining each plaque (25). For those with more than one 
plaque, all plaque areas were added together to calculate TPA. Details of the ultrasound examination 
have been described in a previous publication (26). 
Statistical methods 
Characteristics of the study population were summarised using means with standard deviations (SD) 
or medians with the inter-quartile range for continuous variables, or numbers and percentages for 
categorical variables.  
The distribution of TPA was highly skewed and zero-inflated (Figure 1), which led us to use a 
combination of two models. A logistic regression model was used with presence of plaque (yes/no) as 
an outcome to explore the association of adiposity with having at least one plaque. Secondly, log-
transformed TPA was used as the outcome in a linear regression model to explore the association 
between adiposity and plaque burden excluding those with no recorded plaque. TPA was log-
transformed to improve the approximation to the normal distribution. These two models in 
conjunction are equivalent to using a hurdle model (27), with the logistic regression modelling the 
distribution of zero plaque versus at least one plaque, and the linear regression modelling the 
distribution of the non-zero measures. 
For both outcomes, we investigated the association with four different measures of adiposity: BMI, 
WC, WHR, WHtR. To directly compare the strength of association of each adiposity measure, taking 
account of the different distributions in men and women, we calculated sex-specific standardized 
adiposity scores. by subtracting the sex-specific mean of each adiposity measure from the observed 
value and then dividing by the sex-specific SDs. We fitted a sequence of three models to each of the 
adiposity measures in turn. Model 1 was adjusted for age as a continuous variable and sex. Model 2 
was further adjusted for potential behavioural confounders; smoking (a categorical variable of three 
levels: current smoker, ex-smoker, never-smoker), and years of education (as a continuous variable).  
Model 3 was additionally adjusted for potential biological mediators of the association between 
adiposity and plaque as follows; systolic blood pressure (SBP), HDL-cholesterol, LDL-cholesterol  
and glycated hemoglobin (HbA1c), all as continuous variables. These analyses were restricted to 
participants with all four adiposity measures and all covariates recorded to compare effect sizes.  
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Previous research on adiposity in relation to cIMT has suggested that there may be different 
associations seen in men and women (28). We therefore checked for interactions with sex in the 
associations of adiposity with TPA, by adding interaction terms for all three models. 
Statistical analyses were performed using Stata statistical software (version 14: Stata Corp) (29). 
 
Results 
Of the 5423 subjects for whom we had carotid ultrasound data, we used the subset of 4906 who had 
complete data on all relevant variables. Missing data on education (5%) and HbA1c (2%) were the 
main reasons for subjects being dropped from the analyses. The characteristics of the subset analysed 
were very similar to that of all subjects who had undergone carotid ultrasound examination (data not 
shown).  
The prevalence of carotid plaque and median TPA are shown in Table 1. The prevalence of having at 
least one plaque was 60%. Table 2 shows the means of each adiposity measure by category of plaque 
burden. There was a tendency for the adiposity means to increase across categories of plaque burden 
except for BMI. 
Table 3 shows the odds ratios for the presence of plaque for each of the four adiposity measures. In 
models 1 and 2 only WHR showed some evidence of an association with presence of plaque. This was 
attenuated and became non-significant on adjustment for mediators in model 3.  
Table 4 shows the associations of log-TPA with each adiposity measure. There was evidence of 
positive associations with all four measures in model 2 after adjustment for potential confounders, 
with WHR showing the strongest effect. All associations were attenuated on further adjustment for 
potential mediators, with WHR remaining the only one showing (weak) evidence of an association. 
Tests for interactions between adiposity and sex and adiposity and age on log-TPA were non-
significant (data not shown). 
 
Discussion 
To our knowledge, this is the first study to investigate the burden of carotid plaque and multiple 
adiposity measures in a large population-based study. Our study had three major findings. First, all 
adiposity measures were associated with log-TPA, but the evidence for an association with plaque 
presence was weak except for WHR. Second, the associations between adiposity and carotid plaque 
appeared to be at least partially mediated by traditional CVD risk factors. Thirdly, our main measure 
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of central obesity (WHR) showed the strongest and most consistent association with plaque presence 
and burden.  
Previous studies investigating the association between adiposity and the presence of plaque are scarce, 
and the results are inconsistent (7-12) in part reflecting differences in statistical methods and the 
extent to which adjustments were made separately for potential confounders and mediators.  
Czernichow et al. showed that BMI, WC, and WHR were not associated with carotid plaque 
occurrence after adjustment for traditional CVD risk factors in 1014 healthy adults (9). Several other 
studies however had results that were broadly consistent with our analyses. A French study with 6265 
participants aged 65-years and older showed that frequency of carotid plaque increased as WC and 
WHR increased, but the association became non-significant after the adjustment for traditional CVD 
risk factors (10). On the other hand, WHR had significant associations with the presence of plaque in 
two cross-sectional studies. Chaubey et al. showed that the odds of having plaque increased by 
approximately 30% as WHR increased by 0.1 after adjustment for traditional CVD risk factors (8). 
Finally, an Australian population study showed that those with WHR larger than 0.91 had two-fold 
increased odds for having plaque compared to those with smaller WHR (11).  
The particularly weak association between BMI and the burden of carotid plaque in our analysis after 
adjustment for traditional CVD risk factors is in line with the only two previous study results (13, 20). 
Herder et al. showed that baseline BMI was not associated with future TPA nor change in TPA in a 
13-year follow-up study (13). Selwaness investigated determinants of plaque burden assessed using 
MRI, and BMI was not significantly associated with the burden of plaque (20). We were unable to 
find any other studies that had examined plaque burden in relation to any of our three other measures 
of adiposity.  
The fact that our study has found evidence for adiposity being related to extent of plaque burden 
rather than the presence/absence of plaque per se is intriguing. This may indicate that adiposity 
contributes to the process of the development of existing plaque more than the process of plaque 
initiation. However, because TPA is a continuous measure and contains more information than the 
binary plaque (present/absent) variable this may make an association easier to detect.  
Several studies investigated the association between multiple adiposity measures and IMT and 
compared the effect size. However, their results are inconsistent. After adjustment for traditional CVD 
risk factors, some studies showed abdominal obesity was more strongly associated with IMT (30, 31) 
while in one study BMI showed the largest effect size (9). In another study, BMI and WC showed the 
same effect size (32). It seems which anthropometry measure is the most strongly associated with 
IMT is still inconclusive. 
The potential importance of our finding that TPA is associated with adiposity is underlined by the fact 
that it has been found to be predictive of CVD events. Spence et al. investigated 1686 patients from an 
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atherosclerosis prevention clinic and showed that those in the top TPA quartile had nearly three times 
the odds of stroke and myocardial infarction compared to those in the first TPA quartile after 5-year 
follow up (18). The Tromsø Study compared the associations between myocardial infarction and 
stroke with IMT and TPA. TPA was a strong predictor of future myocardial infarction and stroke, 
while IMT at the common carotid artery was not associated with future events (19, 34). Sillesen et al. 
showed that plaque burden was more strongly associated with coronary artery calcium score than IMT 
(35).  
One of our most striking results is that the association of adiposity with the burden of carotid plaque is 
strongly attenuated by adjustment for biological factors that are plausible mediators of this 
association. Because our study is cross-sectional it is not possible to describe this as definitive 
evidence of mediation, but it is consistent with such an interpretation. Looking at the larger literature 
on mediators of the association between obesity and CVD events, a recent pooled-analysis using 97 
cohort studies showed that half of the risk of coronary heart diseases and stroke was mediated by 
blood pressure, cholesterol, and glucose(36). A more recent report from the ARIC study suggested 
that the association of obesity with coronary heart disease was fully explained by traditional mediators 
(37). These results taken overall suggest that strict control of traditional CVD risk factors including 
lipids and blood pressure could substantially mitigate the harmful effect of obesity on carotid 
atherosclerosis. 
When comparing the effect sizes of four different adiposity measures, WHR showed the largest effect 
size with a significant association with log-TPA followed by WHtR. While these estimated effects 
have wide and overlapping confidence intervals and thus any differences need to be treated 
cautiously, our results do suggest that central (visceral) obesity may play a more important role than 
obesity as measured by BMI.  Visceral adipose tissue is known to pose a greater risk for CVD with its 
stronger association with insulin resistance and dyslipidemia than total fat and subcutaneous adipose 
tissue (38, 39).  It has also been suggested that the visceral adipose tissue contributes to the progress 
of  atherosclerotic change (40).  
Our study has some limitations. Firstly, the cross-sectional design does not allow conclusions 
concerning causality.  Secondly, TPA is essentially a 2-dimensional proxy for the volume of a 3-
dimensional plaque structure. While this may result in measurement error relative to a better 
assessment of plaque volume, using 3-dimensional ultrasound or MRI for example, this is unlikely to 
bias the strength of association with plaque size as long as this is a random measurement error in the 
outcome variable (47). Thirdly, we only had data available for the right carotid artery. However, this 
is unlikely to have generated bias as there is no reason to believe that the strength of association 
between adiposity and plaque will differ between right and left carotid. Fourthly, the prevalence of 
plaque was relatively high in our population. This may be because participants were relatively old and 
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the study was conducted in 2001-02 when the CVD event rate in the population was appreciably 
higher (48). To this extent, whether the strength of association we report here is generalizable to 
contemporary populations is a matter for further investigation. Finally, a particular strength of our 
study is that the data are from a large population-based study with a high response rate. 
In summary, our results suggest that adiposity measures reflecting abdominal obesity such as WHR 
may be more closely associated with plaque burden than the traditional measure of BMI, and that 
these effects may be mediated by established biological risk factors such as blood pressure and lipids. 
Although further studies are needed to investigate the usefulness of these adiposity measures as 
predictors for an individual in a clinical setting assessment of these measures may help to identify a 
high-risk group with advanced carotid plaque. Further research is desirable to investigate the 
prospective association between adiposity and carotid plaque burden. It has been suggested that TPA 
could capture the progress of atherosclerosis more sensitively than IMT because longitudinal plaque 
growth is faster than its growth toward the lumen (13, 51). This would make TPA suitable for 
prospective studies.  
Conclusion 
Adiposity is more consistently associated with extent of plaque burden than with whether an 
individual does or does not have any plaque. Abdominal adiposity appears to show the strongest 
effects. There was evidence that established biomarkers mediate much of this association. It would be 
useful to examine the prospective effect of abdominal obesity on the progress of carotid 
atherosclerosis in a cohort study. 
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Highlights 
* All adiposity measures were associated with total plaque area 
* Most of the associations between plaque burden and adiposity appeared to be partially mediated by 
traditional CVD risk factor 
*Waist-to-hip ratio showed the largest effect size among four adiposity measures 
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Table 1. Participant characteristics of study population. The Tromsø Study 2001-02 
 Participants included in 
the analysis* (n=4906) 
Participants included in 
the analysis with plaque 
**(n=2906) 
Age (years) 
median(IQR) 
66 (60-72)  
 
68 (63-74) 
 
Sex (% of women) 2722 (55.5) 1450 (49.9) 
Current smoker (%) 1249 (25.5) 794 (27.3) 
Ex-smoker (%) 1999 (40.8) 1234 (42.5) 
Education (year) 9.9 (3.6) 9.4 (3.3) 
SBP (mmHg) 143.0 (21.6) 147.3 (21.5) 
Anthropometry 
measures 
  
Height (cm) 167.4 (9.3) 167.3 (9.5) 
Weight (kg) 75.2 (13.9) 75.1 (13.8) 
BMI (kg/m2) 26.8 (4.2) 26.8 (4.1) 
WC (cm) 90.3 (12.2) 91.1 (12.0) 
WHR 0.89 (0.09) 0.90 (0.09) 
WHtR 0.54 (0.07) 0.55 (0.07) 
Blood sample   
HDL cholesterol 
(mmol/l) median(IQR) 
1.43(1.19-1.72) 
 
1.42 (1.18-1.70) 
 
LDL cholesterol 
(mmol/l) 
4.11 (1.07) 4.16 (1.09) 
Triglycerides (mmol/l) 
median (IQR) 
1.34 (0.96-1.90) 
 
1.39 (1.00-1.94) 
 
HbA1C (%) 5.50 (0.80) 5.58 (0.83) 
Comorbidities (self-
report) 
  
Diabetes (%) 222 (4.6) 152 (5.4) 
Myocardial infarction 
(%) 
378  (7.9) 311 (11.0) 
Angina pectoris (%) 501 (10.5) 398 (14.1) 
Stroke (%) 191 (4.0) 148 (5.2) 
Current medication 
(self-report) 
  
Anti hypertensive drug 
(%) 
1194 (24.9) 869 (31.7) 
Lipid lowering drug 
(%) 
708 (15.0) 541 (19.5) 
Carotid variable   
plaque presence (%) 2906 (59.2%) 2906 (100%) 
the number of plaque 
(%) 
  
1 1372 (28.0) 1372 (47.2) 
2 931 (19.0) 931 (32.0) 
3 427 (8.7) 427 (14.7) 
4 134 (2.7) 134 (4.6) 
5 36 (0.7) 36 (1.2) 
6 6 (0.1) 6 (0.2) 
TPA (mm2)  17.6 (10.0-31.3) 
 
 
Data are mean values with standard deviations for continuous variables except for age, triglycerides, HDL 
cholesterol, and TPA which is shown with median and interquartile range. BMI: body mass index, WC: waist 
circumference, WHR: waist-to-hip ratio, WHtR: waist-to-hight ratio, HDL: high-density lipoprotein, LDL: low-
density lipoprotein, HbA1c: glycated haemoglobin, TPA: total plaque area *Participants are restricted to those 
with all main variables and non-missing TPA variable**Participants are restricted to those with all main 
variables and at least one plaque 
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Table 2.  The association between adiposity and TPA quartiles (crude). The Tromsø Study 2001-
02. 
 
 Total 
number* 
BMI 
(kg/m2) 
WC 
(cm) 
WHR WHtR 
Persons without 
plaques 
2000 26.8 (4.3) 89.0 (12.5) 0.87 (0.09) 0.53 (0.07) 
Persons with plaques      
TPA quartile 1 (lowest) 727 26.7(4.2) 89.3 (11.9) 0.88 (0.09) 0.54 (0.07) 
TPA quartile 2 726 27.1 (4.3) 91.2 (12.3) 0.89 (0.09) 0.55 (0.07) 
TPA quartile 3 727 26.6 (3.9) 90.8(11.7) 0.90 (0.09) 0.54 (0.07) 
TPA quartile 4 726 26.7 (4.0) 93.2 (11.7) 0.92 (0.08) 0.55 (0.07) 
Data are mean values with standard deviations. BMI: body mass index, WC: waist circumference, WHR: waist-
to-hip ratio, WHtR: waist-to-hight ratio, TPA: total plaque area *Only the participants with all adiposity 
variables and covariates are used in this table
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Table 3. The association between sex-specific standardized adiposity scores and the presence of plaque (Yes/No) using logistic regression: this 
analysis is restricted to participants with non-missing presence of plaque variable and all variables in the model (n=4906). The Tromsø Study 2001-
02.  
 Model 1 OR (95%CI) p-value Model 2 OR (95%CI) p-value Model 3 OR (95%CI) p-value 
st BMI  0.98 (0.92, 1.04) 0.45 1.03 (0.96, 1.09) 0.45 0.95 (0.88, 1.01) 0.11 
st WC  0.98 (0.92, 1.05) 0.58 1.01 (0.95, 1.08) 0.79 0.92 (0.86, 0.99) 0.03 
st WHR  1.08 (1.01, 1.15) 0.02 1.07 (1.01, 1.15) 0.03 1.01 (0.94, 1.08) 0.87 
st WHtR  1.02 (0.96, 1.08) 0.57 1.04 (0.98, 1.11) 0.21 0.96 (0.90, 1.03) 0.28 
St BMI:standardized body mass index, st WC: standardized waist circumference, st WHR: standardized waist-to-hip ration, st WHtR: standardized waist-to-height ratio, OR: odds ratio, 95% CI: 
95% confidence interval, SD: standard deviation, Model 1: adjusted for age and sex, Model 2: adjust for variables in Model 1 plus other confounders (smoking and education), Model 3: adjusted 
for variables in Model 2 and mediators (systolic blood pressure, HDL cholesterol, LDL-cholesterol, glycated hemoglobin) 
Table 4. The association between sex-specific standardized adiposity scores and log-transformed TPA using linear regression: this analysis is 
restricted to participants with plaque and all variables in the model (n=2906). The Tromsø Study 2001-02. 
 Model 1 β  (95%CI) p-value Model 2 β (95%CI) p-value Model 3 β (95%CI) p-value 
st BMI  0.012 (-0.015, 0.039) 0.38 0.032 (0.004, 0.059) 0.02 0.002 (-0.026, 0.031) 0.87 
st WC  0.031 (0.005, 0.058) 0.02 0.042 (0.015, 0.068) 0.002 0.012 (-0.017, 0.040) 0.42 
st WHR  0.056 (0.029, 0.083) <0.001 0.055 (0.028, 0.081) <0.001 0.030 (0.002, 0.058) 0.04 
st WHtR  0.038 (0.011, 0.065) 0.005 0.046 (0.019, 0.073) 0.001 0.017 (-0.012, 0.045) 0.26 
St BMI: standardized body mass index, st WC: standardized waist circumference, st WHR: standardized waist-to-hip ratio, st WHtR: standardized waist-to-height ratio, β: regression coefficient, 
95% CI: 95% confidence interval, SD: standard deviation, Model 1: adjusted for age and sex, Model 2: adjust for variables in Model 1 plus other confounders (smoking and education), Model 3: 
adjusted for variables in Model 2 and mediators (systolic blood pressure, HDL cholesterol, LDL-cholesterol, glycated hemoglobin) 
 
 
 
 
